Friday, January 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DHS Standardized Test and Evaluation of Biological Threat Agent Detectors

by Global Biodefense Staff
May 15, 2013

Pandemic PreparednessThe U.S Department of Homeland Security (DHS) has selected Health Research Inc. with the Wadsworth Center, New York State Department of Health to develop standard test methods to support field evaluation of technologies used for biological agent detection.

The proposed work will address current gaps in standards by defining field testing needs, methods and performance requirements. The resulting deliverables will include products that will serve as the basis of a national standard for biothreat equipment.

The work requires interaction with the entire biological event response chain including: members of the Laboratory Response Network, National Guard WMD Civil Support Teams, Hazardous Material response units, Federal Bureau of Investigation (FBI) weapons of mass destruction coordinators, Environmental Protection Agency (EPA) and representatives from regional, state and local response units. 

In further describing why Wadsworth Center and Health Research Inc. were selected, DHS states that because the existing Stakeholder Panel for Agent Detection Assays (SPADA) is the only national standard for biothreat detection and device testing, and will be the basis for the field testing for this effort, it is important the performer have experience with the development of biothreat standards as established by SPADA.

The effort is overseen by the DHS, Science and Technology Directorate, Standards Office, Acquisition Support & Operations Analysis, Biological Countermeasures Standards program. Further details are available at FBO.gov. 

Health Research, Inc. is a not-for-profit corporation affiliated with the New York State Department of Health (DOH) and the Roswell Park Cancer Institute (RPCI) a leading cancer research center located in Buffalo, New York.

Tags: DHSMobile Response

Related Posts

New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.
Health Security

Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.

December 7, 2022
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC